BOTHELL, WA -- (MARKET WIRE) -- February 26, 2007 -- Eden Bioscience Corporation (NASDAQ: EDEN) today announced that it has received all shareholder approvals required to proceed with its previously announced sale of the Company's harpin protein technology and substantially all of the assets related to its agricultural and horticultural markets to Plant Health Care, Inc., a subsidiary of Plant Health Care, plc (AIM: PHC). The Company will retain the exclusive worldwide right to sell its harpin protein-based plant health products in the home and garden market. The proposed sale was approved by over two-thirds of the approximately 8.1 million shares entitled to vote on the proposal. As a result, the Company expects to close the sale on or about February 27, 2007.
